Task: Answer the multiple-choice question.
Query: Which drug exhibits a -11.930% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. O=C(c1ccc(NC2=NC3CS(=O)(=O)CC3S2)cc1)N1CCN(c2ccc([N+](=O)[O-])cc2)CC1
b. CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)/C=C/c1ccco1
Answer: b. CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)/C=C/c1ccco1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)/C=C/c1ccco1
CCN(CC(=O)NCc1ccc(Cl)cc1)C(=O)/C=C/c1ccco1
(E)-N-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]-N-ethyl-3-(furan-2-yl)prop-2-enamide